Let x 2 R S C beaphysiologicalsignalwithC channelssampledatrateS for seconds.

Conversational generative AI has demonstrated remarkable promise for empowering biomedical practitioners, but current investigations focus on unimodal text. Multimodal conversational AI has seen rapid progress by leveraging billions of image-text pairs from the public web, but such general-domain vision-language models still lack sophistication in understanding and conversing about biomedical images. In this paper, we propose a cost-efficient approach for training a vision-language conversational assistant that can answer open-ended research questions of biomedical images. The key idea is to leverage a large-scale, broad-coverage biomedical figure-caption dataset extracted from PubMed Central, use GPT-4 to self-instruct open-ended instruction-following data from the captions, and then fine-tune a large general-domain vision-language model using a novel curriculum learning method. Specifically, the model first learns to align biomedical vocabulary using the figure-caption pairs as is, then learns to master open-ended conversational semantics using GPT-4 generated instruction-following data, broadly mimicking how a layperson gradually acquires biomedical knowledge. This enables us to train a Large Language and Vision Assistant for BioMedicine (LLaVA-Med) in less than 15 hours (with eight A100s). LLaVA-Med exhibits excellent multimodal conversational capability and can follow open-ended instruction to assist with inquiries about a biomedical image. On three standard biomedical visual question answering datasets, LLaVA-Med outperforms previous supervised state-of-the-art on certain metrics. To facilitate biomedical multimodal research, we will release our instruction-following data and the LLaVA-Med model.

Recent development in Retrieval-Augmented Large Language Models (LLMs) have shown great promise in biomedical applications. How ever, a critical gap persists in reliably evaluating their curation ability the process by which models select and integrate relevant references while filtering out noise. To address this, we introduce the benchmark for Curation of Retrieval-Augmented LLMs in Biomedicine (CRAB), the first multilingual benchmark tailored for evaluating the biomedical curation of retrieval-augmented LLMs, available in English, French, German and Chinese. By incorporating a novel citation-based evaluation metric, CRAB quantifies the curation performance of retrieval-augmented LLMs in biomedicine. Experimental results reveal significant discrepancies in the curation performance of mainstream LLMs, underscoring the urgent need to improve it in the domain of biomedicine. Our dataset is available at https://huggingface.co/datasets/zhm0/CRAB.

This paper presents a comprehensive evaluation of cost-efficient Large Language Models (LLMs) for diverse biomedical tasks spanning both text and image modalities. We evaluated a range of closed-source and open-source LLMs on tasks such as biomedical text classification and generation, question answering, and multimodal image processing. Our experimental findings indicate that there is no single LLM that can consistently outperform others across all tasks. Instead, different LLMs excel in different tasks. While some closed-source LLMs demonstrate strong performance on specific tasks, their open-source counterparts achieve comparable results (sometimes even better), with additional benefits like faster inference and enhanced privacy. Our experimental results offer valuable insights for selecting models that are optimally suited for specific biomedical applications.

Large Language Models (LLMs) have demonstrated remarkable capabilities across various domains and are moving towards more specialized areas. Recent advanced proprietary models such as GPT-4 and Gemini have achieved significant advancements in biomedicine, which have also raised privacy and security challenges. The construction of specialized generalists hinges largely on high-quality datasets, enhanced by techniques like supervised fine-tuning and reinforcement learning from human or AI feedback, and direct preference optimization. However, these leading technologies (e.g., preference learning) are still significantly limited in the open source community due to the scarcity of specialized data. In this paper, we present the UltraMedical collections, which consist of high-quality manual and synthetic datasets in the biomedicine domain, featuring preference annotations across multiple advanced LLMs.

Conversational generative AI has demonstrated remarkable promise for empowering biomedical practitioners, but current investigations focus on unimodal text. Multimodal conversational AI has seen rapid progress by leveraging billions of image-text pairs from the public web, but such general-domain vision-language models still lack sophistication in understanding and conversing about biomedical images. In this paper, we propose a cost-efficient approach for training a vision-language conversational assistant that can answer open-ended research questions of biomedical images. The key idea is to leverage a large-scale, broad-coverage biomedical figure-caption dataset extracted from PubMed Central, use GPT-4 to self-instruct open-ended instruction-following data from the captions, and then fine-tune a large general-domain vision-language model using a novel curriculum learning method. Specifically, the model first learns to align biomedical vocabulary using the figure-caption pairs as is, then learns to master open-ended conversational semantics using GPT-4 generated instruction-following data, broadly mimicking how a layperson gradually acquires biomedical knowledge. This enables us to train a Large Language and Vision Assistant for BioMedicine (LLaVA-Med) in less than 15 hours (with eight A100s).

As AI emerged as highest valued technology, We used that to create a web application that makes a patient work easier .It detects the disease name based on the symptoms given by the patient and recommends medication for respective disease, precautions to take, diet to follow and workouts to do, so the disease can be minimized. The web application is made with clean and Realtime data by using Machine learning as root. We used flask to create a user-friendly platform.

We introduce Temporal Ensemble Logic (TEL), a monadic, first-order modal logic for linear-time temporal reasoning. TEL includes primitive temporal constructs such as ``always up to $t$ time later'' ($\Box_t$), ``sometimes before $t$ time in the future'' ($\Diamond_t$), and ``$t$-time later'' $\varphi_t$. TEL has been motivated from the requirement for rigor and reproducibility for cohort specification and discovery in clinical and population health research, to fill a gap in formalizing temporal reasoning in biomedicine. Existing logical frameworks such as linear temporal logic are too restrictive to express temporal and sequential properties in biomedicine, or too permissive in semantic constructs, such as in Halpern-Shoham logic, to serve this purpose. In this paper, we first introduce TEL in a general set up, with discrete and dense time as special cases. We then focus on the theoretical development of discrete TEL on the temporal domain of positive integers $\mathbb{N}^+$, denoted as ${\rm TEL}_{\mathbb{N}^+}$. ${\rm TEL}_{\mathbb{N}^+}$ is strictly more expressive than the standard monadic second order logic, characterized by B\"{u}chi automata. We present its formal semantics, a proof system, and provide a proof for the undecidability of the satisfiability of ${\rm TEL}_{\mathbb{N}^+}$. We also include initial results on expressiveness and decidability fragments for ${\rm TEL}_{\mathbb{N}^+}$, followed by application outlook and discussions.

However, existing surveys on LLMs in biomedicine often focus on specific applications or model architectures, lacking a comprehensive analysis that integrates the latest advancements across various biomedical domains. This review, based on an analysis of 484 publications sourced from databases including PubMed, Web of Science, and arXiv, provides an in-depth examination of the current landscape, applications, challenges, and prospects of LLMs in biomedicine, distinguishing itself by focusing on the practical implications of these models in real-world biomedical contexts. Firstly, we explore the capabilities of LLMs in zero-shot learning across a broad spectrum of biomedical tasks, including diagnostic assistance, drug discovery, and personalized medicine, among others, with insights drawn from 137 key studies. Then, we discuss adaptation strategies of LLMs, including fine-tuning methods for both uni-modal and multi-modal LLMs to enhance their performance in specialized biomedical contexts where zero-shot fails to achieve, such as medical question answering and efficient processing of biomedical literature. Finally, we discuss the challenges that LLMs face in the biomedicine domain including data privacy concerns, limited model interpretability, issues with dataset quality, and ethics due to the sensitive nature of biomedical data, the need for highly reliable model outputs, and the ethical implications of deploying AI in healthcare. To address these challenges, we also identify future research directions of LLM in biomedicine including federated learning methods to preserve data privacy and integrating explainable AI methodologies to enhance the transparency of LLMs. As this field of LLM rapidly evolves, continued research and development are essential to fully harness the capabilities of LLMs in biomedicine while ensuring their responsible and effective deployment.

Artificial intelligence (AI) systems have the potential to revolutionize clinical practices, including improving diagnostic accuracy and surgical decision-making, while also reducing costs and manpower. However, it is important to recognize that these systems may perpetuate social inequities or demonstrate biases, such as those based on race or gender. Such biases can occur before, during, or after the development of AI models, making it critical to understand and address potential biases to enable the accurate and reliable application of AI models in clinical settings. To mitigate bias concerns during model development, we surveyed recent publications on different debiasing methods in the fields of biomedical natural language processing (NLP) or computer vision (CV). Then we discussed the methods that have been applied in the biomedical domain to address bias. We performed our literature search on PubMed, ACM digital library, and IEEE Xplore of relevant articles published between January 2018 and December 2023 using multiple combinations of keywords. We then filtered the result of 10,041 articles automatically with loose constraints, and manually inspected the abstracts of the remaining 890 articles to identify the 55 articles included in this review. Additional articles in the references are also included in this review. We discuss each method and compare its strengths and weaknesses. Finally, we review other potential methods from the general domain that could be applied to biomedicine to address bias and improve fairness.The bias of AIs in biomedicine can originate from multiple sources. Existing debiasing methods that focus on algorithms can be categorized into distributional or algorithmic.